Opioids are a subclass of medicines that are naturally present in poppies (Papaver somniferum), a member of the opiate family of plants. This family of medicines has effects similar to morphine by attaching to opioid receptors in the central nervous system. They are mostly employed in medicine to treat pain and induce anaesthesia. In addition, replacement treatment for opioid addiction, causing diarrhoea to stop, treating opioid overdoses, and suppressing cough are also examples of pharmacological uses. There are hazards associated with using opioids. Your tolerance and reliance to these prescription drugs may build with regular usage, necessitating greater and more frequent dosages. Longer-term usage can occasionally result in addiction (or what medical professionals refer to as "opioid use disorder"). Additionally, if taken in excess, opioids can impair breathing and, if abused, can result in a lethal overdose. If you have never taken an opioid before or if you are taking other medications or chemicals that interact with the opioid, your chance of experiencing respiratory depression (slowing or even halting your breathing) rises. Opioids, which can also interact with illnesses, should only be used when absolutely necessary to treat pain, especially when other options are ineffective.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States